Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$383M |
| 2 |
Costco
COST
|
+$267M |
| 3 |
Pfizer
PFE
|
+$231M |
| 4 |
Microsoft
MSFT
|
+$230M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$227M |
Top Sells
| 1 |
CVS Health
CVS
|
+$258M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL RESOURCES INC (HOLDING CO)
GAS
|
+$216M |
| 4 |
Charter Communications
CHTR
|
+$142M |
| 5 |
TE
TECO ENERGY INC
TE
|
+$136M |
Sector Composition
| 1 | Technology | 15.67% |
| 2 | Healthcare | 12.42% |
| 3 | Financials | 11.99% |
| 4 | Consumer Staples | 9.63% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
OMED
1976
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
| $2.88M | 0.01% |
+251,600
| New | +$2.88M |
|
1977
Digi International
DGII
$1.33B
| $2.87M | 0.01% |
252,000
+30,300
| +14% | +$345K |
|
1978
Insmed
INSM
$30.3B
| $2.87M | 0.01% |
197,700
+48,400
| +32% | +$703K |
|
|
ARRY
1979
DELISTED
Array Biopharma Inc
ARRY
| $2.87M | 0.01% |
424,452
+407,000
| +2,332% | +$2.75M |
|
1980
Kennedy-Wilson Holdings
KW
$1.22B
| $2.86M | 0.01% |
127,000
-247,100
| -66% | -$5.57M |
|
|
MIK
1981
DELISTED
Michaels Stores, Inc
MIK
| $2.86M | 0.01% |
118,400
+59,500
| +101% | +$1.44M |
|
1982
Citizens & Northern Corp
CZNC
$311M
| $2.85M | 0.01% |
129,700
-21,500
| -14% | -$472K |
|
1983
Genesis Energy
GEL
$1.98B
| $2.85M | 0.01% |
75,000
+54,300
| +262% | +$2.06M |
|
1984
James Hardie Industries plc
JHX
$11.7B
| $2.85M | 0.01% |
180,900
+15,600
| +9% | +$245K |
|
1985
German American Bancorp
GABC
$1.53B
| $2.84M | 0.01% |
109,350
-5,850
| -5% | -$152K |
|
|
EVRI
1986
DELISTED
Everi Holdings
EVRI
| $2.83M | 0.01% |
1,146,200
+381,700
| +50% | +$943K |
|
|
WMGI
1987
DELISTED
Wright Medical Group Inc
WMGI
| $2.83M | 0.01% |
115,207
-20,904
| -15% | -$513K |
|
|
REGI
1988
DELISTED
Renewable Energy Group, Inc.
REGI
| $2.82M | 0.01% |
332,561
+108,334
| +48% | +$918K |
|
1989
United-Guardian
UG
$36.5M
| $2.82M | 0.01% |
191,900
+10,800
| +6% | +$158K |
|
1990
NatWest
NWG
$59.2B
| $2.81M | 0.01% |
560,300
-1,118,484
| -67% | -$5.61M |
|
|
NETI
1991
DELISTED
Eneti Inc.
NETI
| $2.81M | 0.01% |
87,243
+17,872
| +26% | +$575K |
|
|
ORBC
1992
DELISTED
ORBCOMM, Inc.
ORBC
| $2.81M | 0.01% |
+273,700
| New | +$2.81M |
|
|
ICON
1993
DELISTED
Iconix Brand Group, Inc.
ICON
| $2.8M | ﹤0.01% |
+34,438
| New | +$2.8M |
|
|
SEAC
1994
DELISTED
Seachange International Inc
SEAC
| $2.8M | ﹤0.01% |
46,756
+9,470
| +25% | +$566K |
|
|
TTPH
1995
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $2.79M | ﹤0.01% |
36,450
-2,790
| -7% | -$214K |
|
1996
AllianceBernstein
AB
$4.19B
| $2.79M | ﹤0.01% |
122,400
+99,900
| +444% | +$2.28M |
|
|
MRLN
1997
DELISTED
Marlin Business Services Corp
MRLN
| $2.79M | ﹤0.01% |
143,800
+35,600
| +33% | +$690K |
|
1998
Shore Bancshares
SHBI
$569M
| $2.78M | ﹤0.01% |
236,100
+32,100
| +16% | +$378K |
|
1999
Ambac
AMBC
$407M
| $2.77M | ﹤0.01% |
150,800
+85,566
| +131% | +$1.57M |
|
2000
ASML
ASML
$341B
| $2.77M | ﹤0.01% |
25,207
-103,078
| -80% | -$11.3M |
|